IL13 and Alzheimer disease: In AD, an IL‐4/IL‐13‐rich milieu causes epidermal junctional weakening and loss of the moisture barrier, while IL‐31 from Th2 cells provokes itching that leads to further barrier trauma (the itch‐scratch cycle) [190].